The activation of TGR5 and FXR increased the energy expenditure in BAT, enhanced the browning of iWAT, and improved lipid metabolism in adipose tissues and the liver, therefore reducing adiposity and improving metabolic syndromes. The gene discussed is NR1H4; the disease is metabolic syndrome.